• <strong id="m0u0m"></strong>
  • <optgroup id="m0u0m"></optgroup>
  • <optgroup id="m0u0m"></optgroup>
    <strong id="m0u0m"></strong>
    收藏本站    您好,歡迎光臨上海懋康生物科技有限公司!
    登錄  |   注冊
    當前位置: 首頁> 產品中心> 信號轉導研究相關 > MAPK通路 > MPP+ iodide (N-Methyl-4-Phenylpyridinium Iodide)
    MPP+ iodide (N-Methyl-4-Phenylpyridinium Iodide)
    目錄號 MZ6402-50MG 售價 922.00元
    規格 50mg 運輸溫度 冰袋運輸。
    其他名稱 保存溫度 -20ºC避光干燥保存,至少2年有效。
    CAS號 36913-39-0 有效期
    應用 訂購數量
    產品簡介:

    MPP+ iodide (N-Methyl-4-Phenylpyridinium Iodide)



    產品標簽

    MPP+ iodide;MPTP;帕金森病動物模型;Ferroptosisinhibitor;Necrostatin-1;Ferrostatin-1 (Fer-1);CAS:36913-39-0;


    產品信息: 

    產品名稱

    產品編號

    CAS NO.

    規格

    價格(元)

    MPP+ iodide (N-Methyl-4-Phenylpyridinium Iodide)

    MZ6402-50MG

    36913-39-0

    50mg

    922

    MPP+iodide (N-Methyl-4-Phenylpyridinium Iodide)

    MZ6402-100MG

    36913-39-0

    100mg

    1592

    MPP+iodide (N-Methyl-4-Phenylpyridinium Iodide)

    MZ6402-250MG

    36913-39-0

    250mg

    3522


    產品描述

    MPP+iodide (N-Methyl-4-Phenylpyridinium Iodide)是神經毒素MPTP的活性代謝物,在帕金森病動物模型中選擇性破壞多巴胺能神經元。MPP+主要通過抑制線粒體電子傳遞鏈復合物I,引起ATP耗竭和氧化應激增高,從而誘導神經毒性。MPP+誘導Necrostatin-1 (Nec-1)和 Ferrostatin-1 (Fer-1)敏感的SH-SY5Y細胞壞死,但MPP+誘導的壞死性細胞死亡與鐵壞死是不同的生理過程。


    產品特性

    1) 化學名:1-Methyl-4-phenylpyridin-1-ium iodide

    2) 同義名:N-Methyl-4-Phenylpyridinium Iodide; 1-methyl-4-phenyl-pyridinium, monoiodide; MPP+;N-甲基-4-苯基吡啶鎓碘化物;1-甲基-4-苯基-吡啶鎓碘化物;1-甲基-4-苯基吡啶碘化物;

    3) CAS NO:36913-39-0

    4) 分子式:C12H12IN

    5) 分子量:297.1

    6) 純度:≥98%

    7) 外觀:固體

    8) 溶解性:溶于H2O(100mM)

    9) 化學結構式:


    保存與運輸方法

    保存:-20oC避光干燥保存,至少2年有效。 

    運輸:冰袋運輸。


    注意事項

    1) 關于化合物溶解性:產品特性內的“≥”表明溶于標示濃度,但飽和溶解度未知。不同批次化合物的溶解度會有差異。

    2) 為了讓化合物更好的溶解,可通過37℃加熱或(和)超聲波水浴中震動片刻來處理。若實驗所需濃度過大甚至達產品溶解極限,請添加助溶劑助溶或自行調整濃度。

    3) 本品僅用作科研用途,不可用于臨床或診療用途。

    4) 為了您的安全和健康,請穿實驗服并戴一次性手套操作。

    儲存液制備

              質

    溶劑體積

    濃度

    1mg

    5mg

    10mg

    1mM

    3.3654 mL

    16.8271 mL

    33.6542mL

    5mM

    0.6731mL

    3.3654 mL

    6.7308mL

    10mM

    0.3365 mL

    1.6827 mL

    3.3654 mL

    【溫馨提示】:請根據產品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;MPP+在溶液中不穩定,建議新鮮配制溶液且立即使用。配制好的溶液需避光保存和使用。


    使用方法【源自文獻,僅作參考】

    文獻1,Stahl K, Rahmani S, Prydz A, Skauli N, MacAulay N, Mylonakou MN, Torp R, Skare ?, Berg T, Leergaard TB, Paulsen RE, Ottersen OP, Amiry-Moghaddam M. Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease. PLoS One. 2018 Mar 22;13(3):e0194896. doi: 10.1371/journal.pone.0194896. PMID: 29566083; PMCID: PMC5864064.

    體內研究(動物模型):

    動物模型(Animal Model):C57BL/6J WT and Aqp9-/- mice

    配制方法(Formulation):MPP+ (7.5 μg dissolved in saline)

    實驗方法(Assay):C57BL/6J WT (n = 34) and Aqp9-/- mice (n = 29) were deeply anesthetized with zoletil mixture, Rompunand Fentanyl and then subjected tostereotaxic intrastriatal injections of MPP+ (7.5 μg dissolved in saline) or saline. 1 μl MPP+ solution or saline was injected into the striatum 0.6 mm anterior to Bregma, 2.2 mm laterally and 3.2 mm ventrally at 12 μl/hr using a syringe pump. MPP+ was protected against light during the procedure. The injector was left for 5 minutes to allow diffusion before suture.

    文獻2,Xu J, Gao X, Yang C, Chen L, Chen Z. Resolvin D1 Attenuates Mpp+-Induced Parkinson Disease via Inhibiting Inflammation in PC12 Cells. Med Sci Monit. 2017 Jun 2;23:2684-2691. doi: 10.12659/msm.901995. PMID: 28572562; PMCID: PMC5465971.

    體外研究(細胞實驗):

    細胞類型(Cell types):PC12 cells

    實驗方法(Assay):The in vitro PD model was established by treatment of PC12 cells with250 μM MPP+ for approximately 24 hours.Different concentrations of RvD1 (50, 100, 200 nM) were administrated two hours prior to MPP+ treatment, afterwards, PC12 cells were used for following experiments.

    文獻3,Christensen C, Torsteinsson H, Maier VH, Karlsson K?. Multi-parameter Behavioral Phenotyping of the MPP+ Model of Parkinson's Disease in Zebrafish. Front Behav Neurosci. 2020 Dec 18;14:623924. doi: 10.3389/fnbeh.2020.623924. PMID: 33390914; PMCID: PMC7775599.

    體內研究(動物模型):

    動物模型(Animal Model):Zebrafish larvae

    配制方法(Formulation):Both MPP+ and PBA were dissolved in the system water.

    實驗方法(Assay):Zebrafish larvae were incubated between 1 and 5 dpf in the presence or absence of 500 μM MPP+ at a total volume of 25 ml system water. The drug solutions were freshly prepared and replaced between 11:00 and 12:00 am at 2, 3, and 4 dpf.Deceased larvae were removed daily, but no differences in mortality were observed between MPP+ exposed larvae and untreated larvae.


    相關產品

    貨號

    名稱

    規格

    MZ5271-5MG

    Ferrostatin-1鐵死亡抑制劑

    5mg

    MZ5272-5MG

    Erastin鐵死亡激活劑

    5mg

    MZ6402-50MG

    MPP+ iodide (N-Methyl-4-Phenylpyridinium Iodide)

    50mg

    MZ6403-25MG

    MPTP hydrochloride

    25mg

    MX4558-50UG

    FeRhoNox-1 (Fe2+ indicator)亞鐵離子熒光探針

    50μg

    MX4559-24UG

    FerroOrange (Fe2+ indicator)亞鐵離子熒光探針

    24μg

    MX5211-1MG

    C11 BODIPY 581/591脂質過氧化熒光探針

    1mg

     

     — —Written/Edited by V. Shallan【版權歸MKBio懋康所有】

     

     

    上海懋康生物科技有限公司是一家涉足于生命科學和生物技術領域研究的試劑、儀器和實驗室消耗品與實驗服務工作,主要從事細胞生物學、植物學、分子生物學、免疫學、生物化學、蛋白組學。生物制藥與診斷試劑研發生產等領域。 本公司秉承“以人為本,以誠為信、合同守信”的經營理念。堅持"品質保障"的原則為廣大客戶提供優質產品。

    電話:021-54736159    傳真:021-54736159    手機:18121428569
    郵箱: sales@maokangbio.com
    地址:上海市徐匯區龍吳路2888弄23號902室    
    版權所有:上海懋康生物科技有限公司
    滬ICP備16016464號-1
    华人在线亚洲欧美精品_影音先锋一区二区三区_国产情侣韩国精品名优中字_97久久综合亚洲色hezyo
  • <strong id="m0u0m"></strong>
  • <optgroup id="m0u0m"></optgroup>
  • <optgroup id="m0u0m"></optgroup>
    <strong id="m0u0m"></strong>